SCAM Act
Summary
The SCAM Act (S.3674) expands civil denaturalization grounds for fraud against governmental programs, terrorist affiliation, and certain crimes. It has advanced to the Senate Legislative Calendar but authorizes zero new funding. The bill's impact is procedural and indirect, with no near-term direct market implications for publicly traded companies.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Zero funding authorized—no direct federal spending impact
- 2.Procedural step only; bill is on Senate calendar but not scheduled for floor vote
- 3.No publicly traded companies directly named; any impact is indirect and speculative
Market Implications
This bill has minimal near-term market implications. No publicly traded companies are directly affected by the expansion of civil denaturalization grounds. The most plausible secondary effects—increased legal services demand and marginal compliance costs for government program administrators—are too diffuse and uncertain to drive material changes in stock prices. Investors should not adjust positions based on this legislative development.
Full Analysis
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Expansion of civil denaturalization grounds for individuals who have defrauded a governmental program
Who must act
Health insurance providers offering Medicare Advantage and other government program plans
What happens
Increased scrutiny and potential investigations into beneficiary eligibility could lead to retroactive denials of coverage for services rendered, increasing administrative costs and liability for improper payments
Stock impact
Humana is a top provider of Medicare Advantage plans; enhanced denaturalization enforcement targeting fraud in governmental programs may increase compliance costs and exposure to clawbacks on submitted claims for ineligible beneficiaries
What the bill does
Expanded civil denaturalization grounds for individuals who have defrauded a governmental program
Who must act
Retailers that accept SNAP/EBT benefits as payment for groceries
What happens
Potential for increased audits and restrictions on SNAP benefits usage as part of denaturalization enforcement, indirectly reducing transaction volume from participants found ineligible
Stock impact
Walmart is the largest SNAP retailer in the US; any reduction in SNAP participation due to tighter denaturalization enforcement could decrease high-margin food stamp sales at its stores
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Protecting Health Care and Lowering Costs Act of 2025
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
TRIWEST HEALTHCARE ALLIANCE CORP: $929M Department of Veterans Affairs Contract
Medicare for All Act
Association Health Plans Act
Putting Patients First Healthcare Freedom Act
I CAN Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Presidential Determination Pursuant to Section 303 of the Defense Production Act of 1950, as Amended, on Development, Manufacturing, and Deployment of Large-Scale Energy and Energy‑Related Infrastructure
This presidential memorandum invokes Section 303 of the Defense Production Act (DPA) to accelerate the development, manufacturing, and deployment of large-scale energy and energy-related infrastructure. It authorizes the Secretary of Energy to make necessary purchases, commitments, and financial instruments to expand domestic capabilities in this sector, citing a national energy emergency and the need to avert an industrial resource shortfall.
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.